Strategies to advance translational research into brain barriers
- PMID: 18093565
- DOI: 10.1016/S1474-4422(07)70326-5
Strategies to advance translational research into brain barriers
Abstract
There is a paucity of therapies for most neurological disorders--from rare lysosomal storage diseases to major public health concerns such as stroke and Alzheimer's disease. Advances in the targeting of drugs to the CNS are essential for the future success of neurotherapeutics; however, the delivery of many potentially therapeutic and diagnostic compounds to specific areas of the brain is restricted by the blood-brain barrier, the blood-CSF barrier, or other specialised CNS barriers. These brain barriers are now recognised as a major obstacle to the treatment of most brain disorders. The challenge to deliver therapies to the CNS is formidable, and the solution will require concerted international efforts among academia, government, and industry. At a recent meeting of expert panels, essential and high-priority recommendations to propel brain barrier research forward in six topical areas were developed and these recommendations are presented here.
Similar articles
-
Drug delivery to the central nervous system: a review.J Pharm Pharm Sci. 2003 May-Aug;6(2):252-73. J Pharm Pharm Sci. 2003. PMID: 12935438 Review.
-
[The blood-brain barrier and drug delivery in the central nervous system].Rev Neurol. 2010 Aug;51(3):165-74. Rev Neurol. 2010. PMID: 20645267 Review. Spanish.
-
Drug targeting to the brain.Annu Rev Pharmacol Toxicol. 2007;47:323-55. doi: 10.1146/annurev.pharmtox.47.120505.105237. Annu Rev Pharmacol Toxicol. 2007. PMID: 16961459 Review.
-
Peptide pills for brain diseases? Reality and future perspectives.Ther Deliv. 2013 Apr;4(4):479-501. doi: 10.4155/tde.13.5. Ther Deliv. 2013. PMID: 23557289 Review.
-
Targeting the brain--surmounting or bypassing the blood-brain barrier.Handb Exp Pharmacol. 2010;(197):411-31. doi: 10.1007/978-3-642-00477-3_14. Handb Exp Pharmacol. 2010. PMID: 20217538 Review.
Cited by
-
Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor.Proc Natl Acad Sci U S A. 2013 May 21;110(21):8662-7. doi: 10.1073/pnas.1307152110. Epub 2013 May 6. Proc Natl Acad Sci U S A. 2013. PMID: 23650374 Free PMC article.
-
MicroRNAs regulate human brain endothelial cell-barrier function in inflammation: implications for multiple sclerosis.J Neurosci. 2013 Apr 17;33(16):6857-63. doi: 10.1523/JNEUROSCI.3965-12.2013. J Neurosci. 2013. PMID: 23595744 Free PMC article.
-
Benchmarking in vitro tissue-engineered blood-brain barrier models.Fluids Barriers CNS. 2018 Dec 4;15(1):32. doi: 10.1186/s12987-018-0117-2. Fluids Barriers CNS. 2018. PMID: 30514389 Free PMC article. Review.
-
The blood-brain barrier: geriatric relevance of a critical brain-body interface.J Am Geriatr Soc. 2010 Sep;58(9):1749-57. doi: 10.1111/j.1532-5415.2010.03011.x. J Am Geriatr Soc. 2010. PMID: 20863334 Free PMC article. Review.
-
An update on the therapeutic role of alkylglycerols.Mar Drugs. 2010 Aug 5;8(8):2267-300. doi: 10.3390/md8082267. Mar Drugs. 2010. PMID: 20948908 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
